Financials
Income statement
| Fiscal date | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total reported revenue | 189.2B | 163.3B | 144.3B | 119.8B |
| Cost of revenue | 131.8B | 113.8B | 102.3B | 86.2B |
| Gross profit | 57.4B | 49.5B | 42.1B | 33.6B |
| Operating expense | ||||
| Research & development | 834.9M | 374.8M | 175.8M | — |
| Selling general and admin | 9.7B | 7.6B | 5.8B | 5.4B |
| Other operating expenses | 13.4B | 12.0B | 9.7B | 7.6B |
| Operating income | 16.0B | 15.6B | 15.6B | 11.5B |
| Non operating interest income | ||||
| Income | 1.2B | 969.4M | 380.8M | 247.6M |
| Expense | 616.9M | 515.6M | 419M | 582.5M |
| Other income expense | — | — | — | — |
| Pretax income | 16.5B | 16.8B | 15.8B | 11.3B |
| Tax provision | 6.0B | 5.0B | 4.2B | 1.6B |
| Net income | 10.5B | 17.2B | 13.3B | 9.9B |
| Basic EPS | 34.8 | 62.1 | 49.5 | 39.9 |
| Diluted EPS | 34.8 | 62.0 | 49.4 | 39.8 |
| Basic average shares | 193.4M | 193.3M | 193.0M | 192.9M |
| Diluted average shares | 193.4M | 193.3M | 193.0M | 192.9M |
| EBITDA | 22.3B | 21.3B | 19.9B | 15.1B |
| Net income from continuing op. | 16.5B | 16.8B | 15.8B | 11.3B |
| Minority interests | -3.8B | -5.2B | -3.7B | -2.2B |
| Preferred stock dividends | 0 | 0 | 0 | 0 |